|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-8-11
|
|
pubmed:abstractText |
Zoledronic acid treatment reduces the incidence of skeletal-related events (SREs) in patients with bone metastases from breast, lung, and urologic cancers including prostate and renal cancer. The aim of this study was to evaluate the effect of zoledronic acid on SREs in patients with bone metastases from bladder cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1437-7772
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
382-9
|
|
pubmed:dateRevised |
2011-9-13
|
|
pubmed:meshHeading |
pubmed-meshheading:20354750-Adult,
pubmed-meshheading:20354750-Aged,
pubmed-meshheading:20354750-Antineoplastic Agents,
pubmed-meshheading:20354750-Bone Density Conservation Agents,
pubmed-meshheading:20354750-Bone Neoplasms,
pubmed-meshheading:20354750-Diphosphonates,
pubmed-meshheading:20354750-Drug Administration Schedule,
pubmed-meshheading:20354750-Egypt,
pubmed-meshheading:20354750-Female,
pubmed-meshheading:20354750-Fractures, Bone,
pubmed-meshheading:20354750-Humans,
pubmed-meshheading:20354750-Hypercalcemia,
pubmed-meshheading:20354750-Imidazoles,
pubmed-meshheading:20354750-Kaplan-Meier Estimate,
pubmed-meshheading:20354750-Male,
pubmed-meshheading:20354750-Middle Aged,
pubmed-meshheading:20354750-Pain,
pubmed-meshheading:20354750-Placebo Effect,
pubmed-meshheading:20354750-Prospective Studies,
pubmed-meshheading:20354750-Risk Assessment,
pubmed-meshheading:20354750-Risk Factors,
pubmed-meshheading:20354750-Spinal Cord Compression,
pubmed-meshheading:20354750-Time Factors,
pubmed-meshheading:20354750-Treatment Outcome,
pubmed-meshheading:20354750-Urinary Bladder Neoplasms
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer.
|
|
pubmed:affiliation |
Radiation Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt. mszagh@yahoo.com
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
